跳至主要内容
临床试验/ACTRN12616000480482
ACTRN12616000480482进行中(未招募)未知

A new, low-cost e-health treatment for Alcohol Use Disorder using mental imagery.

Professor David J. Kavanagh0 个研究点目标入组 480 人开始时间: 2016年4月13日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
480

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants will be aged 18 years or over and report consuming >40 gm of ethanol (4 standard drinks)/day on average in the past 4 weeks. They will fulfil criteria for current DSM-5 Alcohol Use Disorder and deny intravenous drug use or >twice-weekly cannabis use in the last month. They will not be in concurrent psychological treatment for substance use, and if on naltrexone or acamprosate, will have been on a stable dose for >4 weeks. If highly dependent on alcohol or drinking >700 gm ethanol/week, they will obtain a medical assessment and agree to any medical treatment that is needed, including a medically supervised detoxification if required. They must have access to a smartphone to be able to use the treatment app.

排除标准

  • Exclusion criteria include insufficient English to read or converse without translation, pregnancy or high dependence on medical care, unmodified hearing impairment, significant cognitive deficit, history of >3 days of psychosis, and acute current suicidality.

研究者

发起方
Professor David J. Kavanagh

相似试验